-
Patients with atrial fibrillation receive anticoagulation therapy as standard. This is supplemented by dual platelet inhibition in the presence of acute coronary syndrome (ACS). The main concern of doctor and patient is the risk of severe bleeding events. What combinations of drugs are possible here? Is acetylsalicylic acid (ASA) an option in combined anticoagulation therapy for these patients?
-
The new US guideline already defines a blood pressure of 130/80 mm Hg measured during the day as hypertension. Literally, overnight, every second US American suddenly became a high-pressure patient. Does hypertension now also have to be redefined in Europe?
-
Atrial fibrillation (A-fib) is still discovered in many patients by chance or only after a stroke. Experts at the ESC 2018, therefore, urged once again that risk patients be screened more regularly for A-fib. After all, diagnosis is an important starting point for reducing the risk of stroke.
-
The results of the ASCEND study published at the ESC Congress 2018 and in the New England Journal of Medicine show what many have always suspected: Fish oil preparations have absolutely no effect on patients with diabetes. According to Professor Louise Bowman, there is no justification for recommending fish oil preparations to protect against cardiovascular events. A reconsideration of the European Guidelines in this respect should, therefore, be considered.
-
Atrial fibrillation (A-fib) is one of the main risk factors for stroke. For a long time, vitamin K antagonists (VKA) such as warfarin were the drugs of choice in anticoagulation therapy for A-fib. Today, however, the ESC guideline recommends new oral anticoagulants (NOAC) for patients with A-fib in the majority of cases.
-
In the year 2018, the ESC again asked - even more than ever - the question of the right method for measuring blood pressure. Meanwhile, there are many different electronic, automatic and semi-automatic blood pressure monitors in addition to the classic type.
-
Whether aspirin should be used to prevent a cardiovascular event remains uncertain. According to the latest studies, the advantages of avoiding severe vascular events are largely offset by the increased risk of bleeding.
-
Prof. Freek W. A. Verheugt in an interview at the ESC 2018 on the influence of mental status on the treatment success of older cardiology patients.
-
Louise Bowman in an interview at the ESC 2018 on the need for a revised version of the guideline recommendations on the supplementation of omega-3 fatty acids.
-
To date, no pharmacological agent to support weight loss has convincingly demonstrated cardiovascular safety in a rigorous clinical trial, said Erin A. Bohula May in an esanum interview during the ESC 2018.
-
From 25 to 29 August 2018, 31,000 participants from 150 countries are expected at the European Cardiology Congress in Munich, making the Congress of the European Society of Cardiology (ESC) one of the world's largest medical congresses.
-
Immuno-oncology has been groundbreaking and provided patients with more valuable months of life. However, response rates still remain low at around 25%, and immunotherapy success in relation to age needs further research.
-
New levels of heat may cause between 9,000 to 40,000 more suicides in the US and Mexico
-
Emergency rooms may be often overwhelmed, and in the heat of the moment, it is important to keep a cool head and yet be open to new recommendations that can help us make wise decisions.
-
Some medical experts are seeing a rise in cases. In this uncommon phenomenon, thumbs and wrists are overstretched for writing messages, causing sharp pain.
-
Mosa Meat, a Dutch-based start-up, is creating the first non-animal meat, fully produced in a laboratory.
-
A 10-year long observational study finds a link between low levels of Vitamin D and an increased incidence of inflammatory diseases of the lung including ILD
-
With the availability of the new PCSK9 inhibitors Alirocumab and Evolocumab, LDL values can be reduced to below 20 mg/dl for the first time. What is the advantage of such low values? Are patients at risk? A new study provides information.
-
Human papillomaviruses play an important role in the development of genital warts and the far more dangerous cervical carcinoma. There are well over 140 different HPV types, of which around 40 can infect the anogenital region.
-
Safety was as expected based on earlier experience with the agent in psoriasis, psoriatic arthritis (PsA), and Crohn’s disease (CD). Based on these results, ustekinumab may have the potential to offer a new treatment option for patients with SLE.
